Salica Investments — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Theremiatheremia.healthinFeb 2025
Theremia develops statistical methods for analyzing clinical trial outcomes, including a Nearest Neighbor Pairing approach to improve Win Ratio estimation of individual causal treatment effects in heterogeneous patient populations.
AI & Machine LearningBiotechDigital HealthParis, FR
Iris Maréchal(CEO)inChloé Geoffroy(Cofounder)in
Co-investorsAgoranovEntrepreneur FirstBpifranceEurazeo
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.